These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7685331)

  • 1. Morphological observations on pancreatic islet blood vessels in low-dose streptozocin-treated mice.
    Papaccio G; Linn T; Chieffi Baccari G
    J Anat; 1993 Feb; 182 ( Pt 1)(Pt 1):45-53. PubMed ID: 7685331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic duct infiltration in the low-dose streptozocin-treated mouse.
    Papaccio G; Strate C; Linn T
    Histol Histopathol; 1994 Jul; 9(3):529-34. PubMed ID: 7981500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural observations on cytotoxic effector cells infiltrating pancreatic islets of low-dose streptozocin treated mice.
    Papaccio G; Esposito V
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(1):5-10. PubMed ID: 1531718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC; Baumann E; Vezys V; Buckingham F
    J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class II antigen expression on the various cells of normal and activated isolated pancreatic islets.
    Ulrichs K; Müller-Ruchholtz W
    Diagn Immunol; 1985; 3(1):47-55. PubMed ID: 3922662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet B cell neoproliferation in early low dose streptozocin induced diabetes in mice: a ducto-endocrine proliferation?
    Papaccio G; Esposito V; Mezzogiorno V
    Acta Morphol Hung; 1991; 39(1):43-52. PubMed ID: 1836928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
    von Herrath M; Holz A
    J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ analysis of pancreatic islets in rats developing diabetes. Appearance of nonendocrine cells with surface MHC class II antigens and cytoplasmic insulin immunoreactivity.
    In't Veld PA; Pipeleers DG
    J Clin Invest; 1988 Sep; 82(3):1123-8. PubMed ID: 3047167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further morphological and biochemical observations on early low dose streptozocin diabetes in mice.
    Papaccio G; Linn T; Federlin K; Volkman A; Esposito V; Mezzogiorno V
    Pancreas; 1991 Nov; 6(6):659-67. PubMed ID: 1780326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulitis and islet microvasculature in type 1 diabetes.
    Papaccio G
    Histol Histopathol; 1993 Oct; 8(4):751-9. PubMed ID: 8305825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity.
    Xu J; Zhang L; Chou A; Allaby T; Bélanger G; Radziuk J; Jasmin BJ; Miki T; Seino S; Renaud JM
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E326-35. PubMed ID: 18042662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of streptozotocin on the ultrastructure of rat pancreatic islets.
    Mythili MD; Vyas R; Akila G; Gunasekaran S
    Microsc Res Tech; 2004 Apr; 63(5):274-81. PubMed ID: 15170757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation of low dose streptozocin diabetes in mice reveals that insulitis is not obligatory for B cell destruction.
    Papaccio G; Chieffi Baccari G; Esposito V
    J Anat; 1992 Dec; 181 ( Pt 3)(Pt 3):403-7. PubMed ID: 1304577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun amino terminal kinase 1 deficient mice are protected from streptozotocin-induced islet injury.
    Fukuda K; Tesch GH; Nikolic-Paterson DJ
    Biochem Biophys Res Commun; 2008 Feb; 366(3):710-6. PubMed ID: 18082135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow traffic to regenerating islets induced by streptozotocin injection and partial pancreatectomy in mice.
    Ohtake K; Saito T; Satoh Y; Kenjo A; Kimura T; Asawa S; Anazawa T; Gotoh M
    Transplant Proc; 2008 Mar; 40(2):449-51. PubMed ID: 18374097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct.
    Nicoletti F; Di Marco R; Papaccio G; Conget I; Gomis R; Bernardini R; Sims JE; Shoenfeld Y; Bendtzen K
    Eur J Immunol; 2003 Aug; 33(8):2278-86. PubMed ID: 12884303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increase in superoxide dismutase counteracts islet vascular alterations in low-dose streptozocin-treated mice.
    Papaccio G; Frascatore S; Pisanti FA
    Histochemistry; 1994 Mar; 101(3):215-21. PubMed ID: 8056621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.